A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.

A Michigan Medicine professor and a U-M medical student created an app to help patients manage HHT, a systemic blood vessel disorder characterized by excessive nose bleeding.

Despite the proven lifesaving benefit of antibiotics for children with this inherited blood disorder, only 18 percent receive them.

Hundreds of thousands of hospital patients get a pricey genetic test. But it’s often unnecessary, a team of U-M clinicians says.

U-M researchers are probing the cause of cancer-related deep vein thrombosis in hopes of developing new therapies.